Literature DB >> 17361488

Comparison of cellular functionality of human mesenchymal stromal cells and PBMC.

H Schmal1, P Niemeyer, M Roesslein, D Hartl, T Loop, N P Südkamp, G B Stark, A T Mehlhorn.   

Abstract

BACKGROUND: Human mesenchymal stromal cells (MSC) and PBMC play significant roles in repair processes following inflammation. Mechanisms of recruitment are still under investigation. METHODS AND
RESULTS: MIP-1alpha induced the chemotactic migration of MSC but not of PBMC. Correlating with this, 7.7% of MSC expressed the chemokine receptor CCR-1, as shown by FACS analysis. In contrast, PBMC did not express CCR-1 or CCR-2 but did express CXCR-4 (81.9%) and CCR-7 (42.2%). Setum induced the chemotaxis of both cell types, and zymosan activation increased the migration of PBMC but not of MSC. Corresponding with this, C5a induced the migration of PBMC but not of MSC. Dose-dependent and -specific adhesion to fibronectin, fibrinogen, collagen type I and collagen type II could be demonstrated for MSC; in contrast, PBMC did not adhere to any of the investigated proteins. Real-time PCR of receptor expression revealed a 12.2-fold higher expression of alphav in MSC compared with PBMC. Incubation of MSC with tumor necrosis factor-alpha (TNFalpha) induced NFkappaB activation and increased the chemotactic response to serum and adhesion to fibronedtin. DISCUSSION: Chemotaxis and adhesion are crucial and differing cell fundtons of MSC and PBMC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361488     DOI: 10.1080/14653240601011557

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  13 in total

1.  Mesenchymal stem cell (MSC) and endothelial progenitor cell (EPC) growth and adhesion in six different bone graft substitutes.

Authors:  J Schultheiss; C Seebach; D Henrich; K Wilhelm; J H Barker; J Frank
Journal:  Eur J Trauma Emerg Surg       Date:  2011-06-07       Impact factor: 3.693

2.  Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells.

Authors:  Hugo R Caires; Tiago Esteves; Pedro Quelhas; Mário A Barbosa; Melba Navarro; Catarina R Almeida
Journal:  J R Soc Interface       Date:  2016-09       Impact factor: 4.118

3.  Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.

Authors:  Claire M Rice; Neil J Scolding
Journal:  Cell Adh Migr       Date:  2010-04-03       Impact factor: 3.405

4.  The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro.

Authors:  Anita Ignatius; Christian Ehrnthaller; Rolf E Brenner; Ludwika Kreja; Philipp Schoengraf; Patricia Lisson; Robert Blakytny; Stefan Recknagel; Lutz Claes; Florian Gebhard; John D Lambris; Markus Huber-Lang
Journal:  J Trauma       Date:  2011-10

5.  IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells.

Authors:  Wolfgang Böcker; Denitsa Docheva; Wolf Christian Prall; Virginia Egea; Emmanouil Pappou; Oliver Rossmann; Cvetan Popov; Wolf Mutschler; Christian Ries; Matthias Schieker
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

6.  Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.

Authors:  Ke Yang; Xiao Qun Wang; Yu Song He; Lin Lu; Qiu Jing Chen; Jing Liu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2010-10-22       Impact factor: 9.951

7.  Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis.

Authors:  Robert A Boomsma; David L Geenen
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies.

Authors:  Steven J Greco; Pranela Rameshwar
Journal:  Biologics       Date:  2008-12

9.  Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion.

Authors:  Bahareh Sayyar; Megan Dodd; Jianping Wen; Shirley Ma; Leah Marquez-Curtis; Anna Janowska-Wieczorek; Gonzalo Hortelano
Journal:  J Tissue Eng       Date:  2012-11-02       Impact factor: 7.813

10.  Early intra-articular complement activation in ankle fractures.

Authors:  Hagen Schmal; Gian M Salzmann; Philipp Niemeyer; Elia Langenmair; Renfeng Guo; Conny Schneider; Maria Habel; Niels Riedemann
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.